SciBase Secures Guarantee Commitment for Rights Issue
SciBase Holding AB has confirmed a guarantee commitment from Bergs Securities AB for its ongoing rights issue of approximately SEK 57.5 million. The guarantee covers SEK 24.2 million of the total issue.
Stockholm, Sweden – SciBase Holding AB announced on September 25, 2026, that Bergs Securities AB has fulfilled its letter of intent to provide a guarantee commitment for the company's ongoing rights issue. The commitment from Bergs Securities amounts to approximately SEK 24.2 million, covering about 42 percent of the total SEK 57.5 million rights issue.
This guarantee, combined with previously secured subscription undertakings totaling approximately SEK 33.3 million (58 percent of the issue), ensures that the entire rights issue is covered. The subscription undertakings were provided by existing shareholders, including prominent investors and members of SciBase's board and management.
The subscription period for the rights issue remains open until September 29, 2026. The subscription price is set at SEK 15 per share. SciBase is a global medical technology company specializing in early detection and prevention in dermatology, utilizing its Nevisense platform.